Antibiotic therapy for Helicobacter pylori

Med Clin North Am. 2006 Nov;90(6):1125-40. doi: 10.1016/j.mcna.2006.07.002.

Abstract

Helicobacter pylori is one of the most common bacterial infections in the world. H pylori infection of the gastric mucosa is the most common cause of peptic ulcers and is believed to be responsible for 50% to 60% of all gastric carcinomas. This infection is difficult to treat because the bacterium is located within the gastric lumen in the mucus and not within the gastric tissue. Antimicrobial therapy for H pylori includes two or three antibiotics plus either a proton pump inhibitor or a histamine receptor antagonist. H pylori readily develops resistance to antibiotics; therefore, if the initial treatment is unsuccessful, repeat treatment should include different antibiotics.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Drug Therapy, Combination
  • Duodenal Ulcer / drug therapy
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Humans
  • Penicillins / immunology
  • Peptic Ulcer / drug therapy

Substances

  • Anti-Bacterial Agents
  • Penicillins